Your browser doesn't support javascript.
loading
Minimal renal toxicity after Rituximab DHAP with a modified cisplatin application scheme in patients with relapsed or refractory diffuse large B-cell lymphoma.
Lisenko, K; McClanahan, F; Schöning, T; Schwarzbich, M A; Cremer, M; Dittrich, T; Ho, A D; Witzens-Harig, M.
Afiliação
  • Lisenko K; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Im Neuenheimer Feld 410, Heidelberg, 69120, Germany. katharina.lisenko@med.uni-heidelberg.de.
  • McClanahan F; Centre for Haemato-Oncology/Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Schöning T; Pharmacy Department, University Hospital Heidelberg, Heidelberg, Germany.
  • Schwarzbich MA; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Im Neuenheimer Feld 410, Heidelberg, 69120, Germany.
  • Cremer M; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Im Neuenheimer Feld 410, Heidelberg, 69120, Germany.
  • Dittrich T; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Im Neuenheimer Feld 410, Heidelberg, 69120, Germany.
  • Ho AD; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Im Neuenheimer Feld 410, Heidelberg, 69120, Germany.
  • Witzens-Harig M; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Im Neuenheimer Feld 410, Heidelberg, 69120, Germany.
BMC Cancer ; 16: 267, 2016 Apr 11.
Article em En | MEDLINE | ID: mdl-27067641

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Cisplatino / Rituximab / Recidiva Local de Neoplasia Tipo de estudo: Guideline Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Cancer Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Cisplatino / Rituximab / Recidiva Local de Neoplasia Tipo de estudo: Guideline Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Cancer Ano de publicação: 2016 Tipo de documento: Article